Advanced search
1 file | 611.34 KB

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

Tom Van Maerken (UGent) , Ali Rihani (UGent) , Alan Van Goethem (UGent) , Anne De Paepe (UGent) , Franki Speleman (UGent) and Jo Vandesompele (UGent)
(2014) CANCER LETTERS. 344(2). p.157-165
Author
Organization
Keywords
p53, pediatric tumors, targeted therapy, MDM2, nutlin, ACUTE LYMPHOBLASTIC-LEUKEMIA, MOLECULE MDM2 ANTAGONISTS, CELL-CYCLE ARREST, TUMOR-SUPPRESSOR, UNITED-STATES, HEMATOLOGICAL MALIGNANCIES, SENSITIZES NEUROBLASTOMA, TRANSCRIPTIONAL ACTIVITY, RETINOBLASTOMA CELLS, ANTITUMOR-ACTIVITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 611.34 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Van Maerken, Tom, Ali Rihani, Alan Van Goethem, Anne De Paepe, Franki Speleman, and Jo Vandesompele. 2014. “Pharmacologic Activation of Wild-type P53 by Nutlin Therapy in Childhood Cancer.” Cancer Letters 344 (2): 157–165.
APA
Van Maerken, T., Rihani, A., Van Goethem, A., De Paepe, A., Speleman, F., & Vandesompele, J. (2014). Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer. CANCER LETTERS, 344(2), 157–165.
Vancouver
1.
Van Maerken T, Rihani A, Van Goethem A, De Paepe A, Speleman F, Vandesompele J. Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer. CANCER LETTERS. 2014;344(2):157–65.
MLA
Van Maerken, Tom, Ali Rihani, Alan Van Goethem, et al. “Pharmacologic Activation of Wild-type P53 by Nutlin Therapy in Childhood Cancer.” CANCER LETTERS 344.2 (2014): 157–165. Print.
@article{4228968,
  author       = {Van Maerken, Tom and Rihani, Ali and Van Goethem, Alan and De Paepe, Anne and Speleman, Franki and Vandesompele, Jo},
  issn         = {0304-3835},
  journal      = {CANCER LETTERS},
  keyword      = {p53,pediatric tumors,targeted therapy,MDM2,nutlin,ACUTE LYMPHOBLASTIC-LEUKEMIA,MOLECULE MDM2 ANTAGONISTS,CELL-CYCLE ARREST,TUMOR-SUPPRESSOR,UNITED-STATES,HEMATOLOGICAL MALIGNANCIES,SENSITIZES NEUROBLASTOMA,TRANSCRIPTIONAL ACTIVITY,RETINOBLASTOMA CELLS,ANTITUMOR-ACTIVITY},
  language     = {eng},
  number       = {2},
  pages        = {157--165},
  title        = {Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer},
  url          = {http://dx.doi.org/10.1016/j.canlet.2013.11.002},
  volume       = {344},
  year         = {2014},
}

Altmetric
View in Altmetric
Web of Science
Times cited: